Hap Trading, LLC Biocryst Pharmaceuticals Inc Call Options Transaction History

Hap Trading, LLC

15 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 14, 2023	BUY	$10.5 - $14.2 $71,400 - $96,560	6,800 Added 11.24%	67,300 $8,000
Q3 2022 Nov 14, 2022	BUY	$10.79 - $14.81 $144,586 - $198,454	13,400 Added 28.45%	60,500 $31,000
Q2 2022 Aug 12, 2022	SELL	$7.89 - $17.88 $164,112 - $371,904	-20,800 Reduced 30.63%	47,100 $9,000
Q1 2022 May 12, 2022	SELL	$11.56 - $19.76 $273,972 - $468,312	-23,700 Reduced 25.87%	67,900 $58,000
Q4 2021 Feb 14, 2022	BUY	$11.18 - $15.46 $488,566 - $675,602	43,700 Added 91.23%	91,600 $98,000
Q3 2021 Nov 10, 2021	BUY	$14.21 - $17.65 $52,577 - $65,304	3,700 Added 8.37%	47,900 $55,000
Q2 2021 Aug 11, 2021	SELL	$9.5 - $17.24 $356,250 - $646,499	-37,500 Reduced 45.9%	44,200 $167,000
Q1 2021 May 14, 2021	SELL	$7.37 - $13.61 $1.18 Million - $2.18 Million	-160,400 Reduced 66.25%	81,700 $139,000
Q4 2020 Feb 16, 2021	BUY	$3.37 - $8.61 $736,682 - $1.88 Million	218,600 Added 930.21%	242,100 $403,000
Q3 2020 Nov 13, 2020	SELL	$3.43 - $5.53 $124,166 - $200,186	-36,200 Reduced 60.64%	23,500 $13,000
Q2 2020 Aug 10, 2020	BUY	$1.9 - $5.61 $25,650 - $75,735	13,500 Added 29.22%	59,700 $45,000
Q1 2020 May 08, 2020	BUY	$1.6 - $4.11 $30,400 - $78,090	19,000 Added 69.85%	46,200 $9,000
Q4 2019 Feb 11, 2020	BUY	$1.59 - $3.45 $43,248 - $93,840	27,200 New	27,200 $12,000
Q3 2019 Nov 12, 2019	SELL	$2.5 - $3.73 $50,250 - $74,973	-20,100 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$2.91 - $9.15 $58,491 - $183,915	20,100 New	20,100 $0

279

172M

625K

739K

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.41B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.